Ferroptosis and cancer prognosis
Ferroptosis and cancer prognosis is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 32k research works in it since 1970. 26.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the mechanisms and implications of ferroptosis in cancer, exploring topics such as the role of lipid peroxidation, the involvement of GPX4, the impact on the tumor microenvironment, and the interplay with immune cells. It also covers the use of RNA-sequencing for gene expression analysis in the context of ferroptosis and cancer.
- Ferroptosis
- Cancer
- Cell Death
- Tumor Microenvironment
- Lipid Peroxidation
- GPX4
- Immune Cells
- Oxidative Stress
- RNA-sequencing
- Gene Expression
- Research works
- 32k fractional, since 1970
- In the world top 10%
- 8.4k per year above
- Top-10% rate
- 26.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +307% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Ferroptosis and cancer prognosis research?
By volume, China and the United States publish the most (12k and 1.5k works in 2022–2025).
By volume, 2022–2025
- 1 China 12k works
- 2 United States 1.5k works
- 3 Japan 310 works
- 4 South Korea 259 works
- 5 India 239 works
- 6 Germany 213 works
- 7 Italy 195 works
- 8 United Kingdom 158 works
- 9 Iran 158 works
- 10 Taiwan 156 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Ferroptosis and cancer prognosis research?
By volume in 2022–2025, Sun Yat-sen University publishes the most Ferroptosis and cancer prognosis research, followed by Nanjing Medical University and Chinese Academy of Medical Sciences & Peking Union Medical College.
By volume, 2022–2025
- 1 Sun Yat-sen UniversityChina 183 works
- 2 Nanjing Medical UniversityChina 151 works
- 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 151 works
- 4 Central South UniversityChina 143 works
- 5 Harbin Medical UniversityChina 113 works
- 6 Shanghai Jiao Tong UniversityChina 109 works
- 7 Huazhong University of Science and TechnologyChina 108 works
- 8 Fujian Medical UniversityChina 106 works
- 9 Wuhan UniversityChina 106 works
- 10 China Medical UniversityChina 104 works
Who are the leading researchers in Ferroptosis and cancer prognosis?
The most-cited researchers publishing on Ferroptosis and cancer prognosis include Gad Getz, Dirk Schadendorf and Charles M. Perou.
- 1 Gad Getz United States 6.2k citations
- 2 Dirk Schadendorf Germany 4.4k citations
- 3 Charles M. Perou United States 4.2k citations
- 4 Guido Kroemer France 4.2k citations
- 5 Gordon B. Mills United States 3.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Ferroptosis and cancer prognosis research done?
The largest centres of Ferroptosis and cancer prognosis research in 2022–2025 are Shanghai (China), Beijing (China), Guangzhou (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Baise City, Xi’an and Nantong.
Largest cities, 2022–2025
Where it is the local speciality
- Baise CityCN · 30.2 works27×
- Xi’anCN · 25.3 works20×
- NantongCN · 141.7 works20×
- LuzhouCN · 69.1 works18×
Location quotient: how much more of its research is in Ferroptosis and cancer prognosis than the world average.
Where is the best place to study Ferroptosis and cancer prognosis?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Shanghai University of Traditional Chinese Medicine and Nanjing Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 73.0 | 30.4% | 10.1× | 151 | +263.2% |
| 2 | Shanghai University of Traditional Chinese MedicineChina | 73.0 | 44.2% | 17.1× | 52 | +320.1% |
| 3 | Nanjing Medical UniversityChina | 72.5 | 30.2% | 19.2× | 151 | +407.8% |
| 4 | Southern Medical UniversityChina | 72.3 | 34.8% | 17.2× | 96 | +275.2% |
| 5 | China Medical UniversityChina | 69.9 | 34.2% | 20.9× | 104 | +163.1% |
| 6 | Harbin Medical UniversityChina | 69.7 | 28.5% | 36.5× | 114 | +342.2% |
| 7 | Guangzhou Medical UniversityChina | 69.6 | 33.2% | 16.4× | 68 | +618.4% |
| 8 | Sun Yat-sen UniversityChina | 69.3 | 33.7% | 7.3× | 183 | +300.1% |
| 9 | Wenzhou Medical UniversityChina | 69.2 | 30.3% | 16.7× | 90 | +1021.0% |
| 10 | Nanchang UniversityChina | 68.6 | 29.7% | 11.4× | 86 | +563.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Ferroptosis and cancer prognosis research growing?
Output in 2018–2022 was 307% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Ferroptosis and cancer prognosis.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.